The effect of rosuvastatin on incident pneumonia: Results from the JUPITER trial

CMAJ. Canadian Medical Association Journal

Volumn 184, Issue 7, 2012, Pages

  Novack, Victor ^a,b   MacFadyen, Jean ^c   Malhotra, Atul ^c   Almog, Yaniv ^a   Glynn, Robert J ^c   Ridker, Paul M ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ROSUVASTATIN;

AGE; ARTICLE; CARDIOVASCULAR DISEASE; FOLLOW UP; GASTROINTESTINAL INFECTION; GENDER; GYNECOLOGIC INFECTION; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; METABOLIC SYNDROME X; MYCOSIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; SEPSIS; SMOKING; SOFT TISSUE INFECTION; URINARY TRACT INFECTION; VIRUS INFECTION;

EID: 84859829527     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.111017     Document Type: Article

References (21)

1. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
2. Almog Y, Novack V, Eisinger M, et al. The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med 2007;35:372-8. (Pubitemid 46148524)
3. Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110: 880-5. (Pubitemid 39096018)
4. Hackam DG, Mamdani M, Li P, et al. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006;367:413-8. (Pubitemid 43184262)
5. Thomsen RW, Riis A, Kornum JB, et al. Preadmission use of statins and outcomes after hospitalization with pneumonia: population- based cohort study of 29,900 patients. Arch Intern Med 2008; 168:2081-7.
6. Schlienger RG, Fedson DS, Jick SS, et al. Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy 2007;27:325-32. (Pubitemid 46327900)
7. van de Garde EM, Hak E, Souverein PC, et al. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 2006;61:957-61. (Pubitemid 44787165)
8. Myles PR, Hubbard RB, McKeever TM, et al. Risk of community- acquired pneumonia and the use of statins, ACE inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 2009;18:269-75.
9. Mortensen EM, Restrepo MI, Anzueto A, et al. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res 2005;6:82.
10. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005; 4: 977-87.
11. Majumdar SR, McAlister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community-acquired pneumonia: population based prospective cohort study. BMJ 2006;333:999.
12. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007; 166:348-54. (Pubitemid 47216808)
13. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
14. Glynn RJ, Danielson E, Fonseca FA, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009;360:1851-61.
15. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005;162:975-82. (Pubitemid 41619468)
16. Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. BMJ 1996;312:364-7. (Pubitemid 26049407)
17. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84:1065-73.
18. Cox D. Regression models and life tables. J R Stat Soc Series B Stat Methodol 1972;187-220.
19. Kruger PS, Harward ML, Jones MA, et al. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial. Am J Respir Crit Care Med 2011;183:774-81.
20. Merx MW, Liehn EA, Graf J, et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation 2005; 112: 117-24. (Pubitemid 40962577)
21. Novack V, Eisinger M, Frenkel A, et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med 2009;35:1255-60.